6. Henry Schein ( HSIC) distributes health care products and services to health care practitioners, government and other institutions. It serves in two segments: health care distribution and technology. HSIC will announce third-quarter results on Nov. 1. Net income for the third quarter of 2011 is estimated at $93.86 billion, or $1.01 per share, compared to $87.89 million, or 94 cents per share, in the year-ago quarter. Sales are forecast at $2.07 billion, up 9% from $1.89 billion in the third quarter of 2010. Gross margin for the quarter is seen increasing to 28.70% from 28.38% in the year-earlier quarter. Cash flow per share is seen at $1.36, compared to 53 cents in 2010 third quarter. Of the 16 analysts covering the stock, 50% recommend a buy and 44% suggest a hold. Analysts polled by Bloomberg expect the stock to gain an average 8.6% to $75.64 from current levels over the next 12 months.